BRÈVE publiée le 28/02/2024 à 18:12, il y a 6 mois 21 jours Fuller, Smith & Turner PLC mène un rachat d'actions propre Rachat D'actions London Stock Exchange Fuller, Smith & Turner PLC Numis Securities Actions En Trésorerie
BRÈVE publiée le 28/02/2024 à 18:12, il y a 6 mois 21 jours Fuller, Smith & Turner PLC Conducts Own Share Repurchase London Stock Exchange Share Buyback Fuller, Smith & Turner PLC Numis Securities Shares In Treasury
COMMUNIQUÉ DE PRESSE publié le 28/02/2024 à 18:12, il y a 6 mois 21 jours Fuller, Smith & Turner PLC: Transaction in Own Shares Fuller, Smith & Turner PLC announces the purchase of 15,000 'A' ordinary shares at prices ranging from 594.00GBp to 596.00GBp as part of its share buyback program London Stock Exchange Share Buyback Program Fuller, Smith & Turner PLC Numis Securities Limited Own Shares
BRÈVE publiée le 27/02/2024 à 18:40, il y a 6 mois 22 jours Fuller, Smith & Turner PLC annonce le rachat de ses propres actions Rachat D'actions Droits De Vote Marché Boursier Fuller's Capital Émis
BRÈVE publiée le 27/02/2024 à 18:40, il y a 6 mois 22 jours Fuller, Smith & Turner PLC announces repurchase of its own shares Voting Rights Share Buyback Stock Market Fuller's Issued Capital
COMMUNIQUÉ DE PRESSE publié le 27/02/2024 à 18:40, il y a 6 mois 22 jours Fuller, Smith & Turner PLC: Transaction in Own Shares Fuller, Smith & Turner PLC announces purchase of 20,000 'A' ordinary shares as part of share buyback program. Company to hold repurchased shares in Treasury Ordinary Shares Share Buyback Program Treasury Fuller, Smith & Turner PLC Numis Securities Limited
BRÈVE publiée le 26/02/2024 à 19:20, il y a 6 mois 23 jours Fuller, Smith & Turner PLC annonce une transaction sur ses propres actions Rachat D'actions London Stock Exchange Droits De Vote Fuller, Smith & Turner PLC Numis Securities Limited
BRÈVE publiée le 26/02/2024 à 19:20, il y a 6 mois 23 jours Fuller, Smith & Turner PLC Announces Share Transaction Voting Rights London Stock Exchange Share Buyback Fuller, Smith & Turner PLC Numis Securities Limited
COMMUNIQUÉ DE PRESSE publié le 26/02/2024 à 19:20, il y a 6 mois 23 jours Fuller, Smith & Turner PLC: Transaction in Own Shares Fuller, Smith & Turner PLC announces the purchase of 20,000 of its 'A' ordinary shares at prices between 596.00 GBp and 598.00 GBp as part of its share buyback program London Stock Exchange Share Buyback Program Fuller Smith Turner PLC Own Shares Transaction
BRÈVE publiée le 23/02/2024 à 18:29, il y a 6 mois 26 jours Fuller, Smith & Turner PLC annonce un rachat d'actions Rachat D'actions London Stock Exchange Numis Securities Limited Fuller's Gestion De Capital
Publié le 20/09/2024 à 17:40, il y a 12 heures 44 minutes Availability of the 2024 Half-Year Financial Report
Publié le 20/09/2024 à 17:40, il y a 12 heures 44 minutes Mise à disposition du Rapport Financier Semestriel 2024
Publié le 20/09/2024 à 23:40, il y a 6 heures 44 minutes Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Publié le 20/09/2024 à 23:30, il y a 6 heures 54 minutes Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Publié le 20/09/2024 à 23:00, il y a 7 heures 24 minutes AI/ML Innovations Inc. Provides Second Status Update
Publié le 20/09/2024 à 22:30, il y a 7 heures 54 minutes Electric Metals Announces Changes to its Board of Directors
Publié le 20/09/2024 à 22:15, il y a 8 heures 9 minutes Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Publié le 20/09/2024 à 22:58, il y a 7 heures 25 minutes Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023
Publié le 20/09/2024 à 21:00, il y a 9 heures 24 minutes Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Publié le 20/09/2024 à 20:14, il y a 10 heures 9 minutes EQS-Adhoc: GRAMMER AG sells TMD Group in North America
Publié le 20/09/2024 à 19:50, il y a 10 heures 34 minutes BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Publié le 20/09/2024 à 19:47, il y a 10 heures 37 minutes EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma